Age
Item
subject is >18 years old
boolean
C0001779 (UMLS CUI [1])
Informed Consent | Release Personal Health Information
Item
subject has agreed to participate in the study by signing the "patient informed consent" and/or has authorized the collection and disclosure of their personal health information by signing the "patient data collection form".
boolean
C0021430 (UMLS CUI [1])
C1283071 (UMLS CUI [2,1])
C4045976 (UMLS CUI [2,2])
Indication Drug-Eluting Stent | Drug-Eluting Stent Specified Lesion
Item
there is an indication for a drug-eluting stent and a clinical decision to use endeavor resolute in all the lesions found.
boolean
C3146298 (UMLS CUI [1,1])
C1322815 (UMLS CUI [1,2])
C1322815 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
C0221198 (UMLS CUI [2,3])
Protocol Compliance
Item
subject is able and willing to co-operate and to comply with the study protocol and undergo follow-up requirements.
boolean
C0525058 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
subject is a childbearing or breastfeeding female.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Aspirin allergy | Heparin allergy | Hypersensitivity Clopidogrel | Hypersensitivity Ticlopidine | Hypersensitivity Zotarolimus | Hypersensitivity Sirolimus | Hypersensitivity Tacrolimus | Hypersensitivity Pharmaceutical Preparations Similar | Hypersensitivity Analogue | Hypersensitivity Derivative | Hypersensitivity Cobalt | Hypersensitivity Chromium | Allergy to nickel | Hypersensitivity Molybdenum | Contrast media allergy
Item
subject has a known hypersensitivity or allergy to acetylsalicylic acid, heparin, clopidogrel, ticlopidine, drugs such as zotarolimus, rapamycin, tacrolimus, sirolimus or other similar drugs, or any other analog or derivative drug, cobalt, chrome, nickel, molybdenum or contrast media.
boolean
C0004058 (UMLS CUI [1])
C0571776 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0040207 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C1700035 (UMLS CUI [5,2])
C0020517 (UMLS CUI [6,1])
C0072980 (UMLS CUI [6,2])
C0020517 (UMLS CUI [7,1])
C0085149 (UMLS CUI [7,2])
C0020517 (UMLS CUI [8,1])
C0013227 (UMLS CUI [8,2])
C2348205 (UMLS CUI [8,3])
C0020517 (UMLS CUI [9,1])
C0243071 (UMLS CUI [9,2])
C0020517 (UMLS CUI [10,1])
C1527240 (UMLS CUI [10,2])
C0020517 (UMLS CUI [11,1])
C0009148 (UMLS CUI [11,2])
C0020517 (UMLS CUI [12,1])
C0008574 (UMLS CUI [12,2])
C1690547 (UMLS CUI [13])
C0020517 (UMLS CUI [14,1])
C0026402 (UMLS CUI [14,2])
C0570562 (UMLS CUI [15])
Medical contraindication Anticoagulants | Medical contraindication Antiplatelet Agents
Item
subject has a contraindication to anticoagulants and/or antiplatelets.
boolean
C1301624 (UMLS CUI [1,1])
C0003280 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0085826 (UMLS CUI [2,2])
Lesion Preventing Balloon Angioplasty
Item
subject's lesion might prevent proper balloon inflation during angioplasty.
boolean
C0221198 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0002996 (UMLS CUI [1,3])
Angioplasty Primary | Emergency Angioplasty
Item
primary or rescue angioplasty.
boolean
C0162577 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0013956 (UMLS CUI [2,1])
C0162577 (UMLS CUI [2,2])
Drug-Eluting Stents Quantity | Exception Drug-Eluting Stents Specified
Item
subject has one or more drug-eluting stents other than endeavor resolute in other lesions.
boolean
C1322815 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C1322815 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
Therapeutic procedure elective Drug-Eluting Stents | Exception Drug-Eluting Stents Specified
Item
intention for elective treatment with other drug-eluting stent other than endeavor resolute.
boolean
C0087111 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
C1322815 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C1322815 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
Medical condition Associated with Life Expectancy
Item
current medical condition is associated with a life expectancy ≤ 12 months.
boolean
C3843040 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0023671 (UMLS CUI [1,3])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device | Clinical Study Follow-up Incomplete
Item
subject is participating in another investigational drug or device study and has not completed the follow-up required for that study at least 30 days prior to signing the consent form in this study. subject can only be enrolled once in this study.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
C3274571 (UMLS CUI [4,1])
C0205257 (UMLS CUI [4,2])
Medical condition Preventing Follow-up | Medical condition Study Subject Participation Status Limited
Item
subject has a medical condition preventing follow-up as established in the protocol or limiting participation in this study.
boolean
C3843040 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
Follow-up Participation Uncertain
Item
subject cannot guarantee follow-up.
boolean
C3274571 (UMLS CUI [1,1])
C0679823 (UMLS CUI [1,2])
C0087130 (UMLS CUI [1,3])